StockNews.com Downgrades Immunic (NASDAQ:IMUX) to Sell
Immunic (NASDAQ:IMUX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Several other research firms have also weighed in on IMUX. HC Wainwright assumed coverage on shares of Immunic in a report on […]
Immunic (NASDAQ:IMUX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Several other research firms have also weighed in on IMUX. HC Wainwright assumed coverage on shares of Immunic in a report on […]